Vanda Pharmaceuticals | VNDA - PE Price to Earnings

Stock Price
7.15
Daily Change
0.33 4.77%
Monthly
-13.71%
Yearly
48.54%
Q1 Forecast
6.91

Vanda Pharmaceuticals reported 16.79 in PE Price to Earnings for its fiscal quarter ending in June of 2023.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Akebia Therapeutics 1.63K 1.6K Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Anika Therapeutics 47.54 27.2 Jun/2024
AstraZeneca 27.29 5.8 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics 23.16 7.7 Dec/2025
J&J 23.62 0.86 Dec/2025
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Merck 13.92 5.08 Dec/2025
Moderna 27.22 14.51 Jun/2023
Novartis 17.79 1.74 Dec/2025
Pfizer 14.48 5.18 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sanofi 11.99 1.58 Dec/2025
Takeda 235.05 184.95 Dec/2025
Teva Pharmaceutical Industries 10.11 1.04 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Veracyte 45.3 5.4 Dec/2025